Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

478 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Trends in use of neoadjuvant systemic therapy in patients with clinically node-positive breast cancer in Europe: prospective TAXIS study (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101).
Tausch C, Däster K, Hayoz S, Matrai Z, Fitzal F, Henke G, Zwahlen DR, Gruber G, Zimmermann F, Andreozzi M, Goldschmidt M, Schulz A, Maggi N, Saccilotto R, Heidinger M, Mueller A, Tampaki EC, Bjelic-Radisic V, Sávolt Á, Smanykó V, Hagen D, Müller DJ, Gnant M, Loibl S, Markellou P, Bekes I, Egle D, Ruhstaller T, Muenst S, Kuemmel S, Vrieling C, Satler R, Becciolini C, Bucher S, Kurzeder C, Simonson C, Fehr PM, Gabriel N, Maráz R, Sarlos D, Dedes KJ, Leo C, Berclaz G, Fansa H, Hager C, Reisenberger K, Singer CF, Montagna G, Reitsamer R, Winkler J, Lam GT, Fehr MK, Naydina T, Kohlik M, Clerc K, Ostapenko V, Lelièvre L, Heil J, Knauer M, Weber WP. Tausch C, et al. Among authors: gnant m. Breast Cancer Res Treat. 2023 Sep;201(2):215-225. doi: 10.1007/s10549-023-06999-9. Epub 2023 Jun 25. Breast Cancer Res Treat. 2023. PMID: 37355526 Free PMC article.
Do we need HER-2/neu testing for all patients with primary breast carcinoma?
Taucher S, Rudas M, Mader RM, Gnant M, Dubsky P, Bachleitner T, Roka S, Fitzal F, Kandioler D, Sporn E, Friedl J, Mittlböck M, Jakesz R. Taucher S, et al. Among authors: gnant m. Cancer. 2003 Dec 15;98(12):2547-53. doi: 10.1002/cncr.11828. Cancer. 2003. PMID: 14669272 Free article.
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.
Jakesz R, Jonat W, Gnant M, Mittlboeck M, Greil R, Tausch C, Hilfrich J, Kwasny W, Menzel C, Samonigg H, Seifert M, Gademann G, Kaufmann M, Wolfgang J; ABCSG and the GABG. Jakesz R, et al. Among authors: gnant m. Lancet. 2005 Aug 6-12;366(9484):455-62. doi: 10.1016/S0140-6736(05)67059-6. Lancet. 2005. PMID: 16084253 Free article.
Breast conservation: evolution of surgical strategies.
Fitzal F, Gnant M. Fitzal F, et al. Among authors: gnant m. Breast J. 2006 Sep-Oct;12(5 Suppl 2):S165-73. doi: 10.1111/j.1075-122X.2006.00330.x. Breast J. 2006. PMID: 16958997 Review.
Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients.
Fitzal F, Riedl O, Wutzl L, Draxler W, Rudas M, Pluschnig U, Handl-Zeller L, Dubsky P, Bachleitner-Hofmann T, Steger G, Jakesz R, Gnant M. Fitzal F, et al. Among authors: gnant m. Breast Cancer Res Treat. 2007 May;103(1):45-52. doi: 10.1007/s10549-006-9325-6. Epub 2007 Apr 7. Breast Cancer Res Treat. 2007. PMID: 17417725
Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14.
Steger GG, Galid A, Gnant M, Mlineritsch B, Lang A, Tausch C, Rudas M, Greil R, Wenzel C, Singer CF, Haid A, Pöstlberger S, Samonigg H, Luschin-Ebengreuth G, Kwasny W, Klug E, Kubista E, Menzel C, Jakesz R; ABCSG-14. Steger GG, et al. Among authors: gnant m. J Clin Oncol. 2007 May 20;25(15):2012-8. doi: 10.1200/JCO.2006.09.1777. J Clin Oncol. 2007. PMID: 17513805 Clinical Trial.
The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).
Taucher S, Steger GG, Jakesz R, Tausch C, Wette V, Schippinger W, Kwasny W, Reiner G, Greil R, Dubsky P, Poestlberger S, Tschmelitsch J, Samonigg H, Gnant M; Austrian Breast and Colorectal Cancer Study Group-07. Taucher S, et al. Among authors: gnant m. Breast Cancer Res Treat. 2008 Nov;112(2):309-16. doi: 10.1007/s10549-007-9844-9. Epub 2007 Dec 14. Breast Cancer Res Treat. 2008. PMID: 18080748 Clinical Trial.
Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17).
Mlineritsch B, Tausch C, Singer C, Luschin-Ebengreuth G, Jakesz R, Ploner F, Stierer M, Melbinger E, Menzel C, Urbania A, Fridrik M, Steger G, Wohlmuth P, Gnant M, Greil R; Austrian Breast, Colorectal Cancer Study Group (ABCSG). Mlineritsch B, et al. Among authors: gnant m. Breast Cancer Res Treat. 2008 Nov;112(1):203-13. doi: 10.1007/s10549-007-9843-x. Epub 2007 Dec 22. Breast Cancer Res Treat. 2008. PMID: 18158620 Clinical Trial.
478 results